Incomplete penetrance in familial Alzheimer's disease with PSEN1 Ala260Gly mutation.
DNA methylation
Presenilin mutation
cognitive reserve
epigenetic
neurodegenerative disease
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
08
11
2019
accepted:
13
04
2020
pubmed:
25
4
2020
medline:
15
5
2021
entrez:
25
4
2020
Statut:
ppublish
Résumé
Presenilin1 (PSEN1) gene is the most common known genetic cause of early-onset familial Alzheimer's disease. We describe an Italian family with the known p.Ala260Gly mutation in PSEN1 gene. The presence of an asymptomatic 64-year-old male carrying the mutation provides evidence of a possible incomplete penetrance leading to a wider range of age at onset. In order to evaluate whether or not epigenetic modifications could contribute to the phenotypic heterogeneity, we assessed global DNA methylation levels which resulted significantly higher in the three females than in their presymptomatic brother. The study suggests that DNA methylation can contribute to slowing down or possibly protecting from the manifestation of symptoms even in monogenic diseases, emphasizing the great complexity of familial Alzheimer's disease.
Identifiants
pubmed: 32328830
doi: 10.1007/s10072-020-04421-6
pii: 10.1007/s10072-020-04421-6
doi:
Substances chimiques
PSEN1 protein, human
0
Presenilin-1
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2263-2266Subventions
Organisme : Ente Cassa di Risparmio di Firenze
ID : 2015.0713
Organisme : Airalzh onlus
ID : COOP
Organisme : Università di Firenze
ID : fondi ateneo per la ricerca